Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures XRTX Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue RD Costs Shares Climb HSBC Q1 2026 Earnings Modest EPS Beat Amid Quiet Trading Session KT Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions